Further, in obese mice, decreased lipogenic gene expression, de novo lipogenesis, and decreased hepatic steatosis and glucose tolerance mediated by SHP were also dependent on hepatic DNMT3A. The gene discussed is NR0B2; the disease is fatty liver disease.